As of 2025-04-29, the Intrinsic Value of Clearmind Medicine Inc (CMND.CN) is -13.60 CAD. This CMND.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.60 CAD, the upside of Clearmind Medicine Inc is -949.96%.
Based on its market price of 1.60 CAD and our intrinsic valuation, Clearmind Medicine Inc (CMND.CN) is overvalued by 949.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.60 - -13.60 | -13.60 | -949.96% |
| DDM - Stable | (37.78) - (172.23) | (105.00) | -6662.8% |
| DDM - Multi | (35.30) - (124.99) | (55.05) | -3540.3% |
| Market Cap (mil) | 5.07 |
| Beta | 0.25 |
| Outstanding shares (mil) | 3.17 |
| Enterprise Value (mil) | -0.36 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.23% |
| Cost of Debt | 5.00% |
| WACC | 5.46% |